Austria
Canada
Czech Republic
France
Germany
Hungary
Latin America
Mauritius
Netherlands
Poland
Spain
Switzerland
Australia
China
Japan
Malaysia
Philippines
Taiwan
Fine Chemicals Corporation
Beta Healthcare
Kama
Nigeria
Shelys
Sustainability Overview
Our vision, “to deliver value to all our stakeholders as a responsible corporate citizen that provides high quality, affordable medicines and products globally", encapsulates the Group’s inherent approach of conducting business ethically, with integrity and with a commercial wisdom which strives to enhance the economic and social well-being of our patients, consumers, investors, employees, customers and business partners.
OUR APPROACH TO SUSTAINABILITY
We recognise that doing business in a sustainable manner is integral to ensuring our future viability. As such sustainability considerations underpin our strategy and are integrated into our day-to-day-activities.
Our material sustainability issues are grouped into 10 sustainability objectives which are aligned to the Group’s strategic objectives, the related capitals and the relevant key performance indicators ("KPIs"). The Audit & Risk Committee reviews and approves the sustainability objectives and the related KPIs. The Board monitors the sustainability performance with reference to these KPIs on a regular basis.
Material sustainability issues are determined through ongoing interactions with our key stakeholders with reference to:
• external factors impacting the Group’s business model and pursuit of strategic objectives;
• key business risks impacting the Group’s sustainability;
• the value exchange and/or opportunity cost of the applied intellectual, manufactured, human, social & relationship, natural and financial capitals to the business as well as the responsible management of these; and
• our responsibility to stakeholders and transparency in reporting with reference to the GRI Sustainability Reporting Standards, King IV, Companies Act of South Africa, BBBEE Codes in South Africa, the JSE/FTSE Responsible Investment Index, the Carbon Disclosure Project and the UN Global Compact.
ASSURANCE
Assurance in respect of the sustainability KPIs is obtained by means of a combined assurance approach, with ERM providing assurance on the key environmental, health and safety indicators in line with the AccountAbility AA1000 Assurance Standard, PwC providing assurance on the financial indicators and other assurance providers such as the Group’s Internal Audit and Empowerdex providing assurance on the balance of the indicators reported.
Contact Details
Downloads
2018 Supplementary Sustainability Documents:
•CDP Climate Change Disclosure PDF 149.6KB
•CDP Water Security Disclosure PDF 164.4KB
•Environmental Management Principles PDF 145KB
•Equity Report - Fine Chemicals Workforce Profile PDF 171KB
•Equity Report - South African Operations Workforce Profile PDF 170KB
•ERM Assurance Statement PDF 307.1KB
•PwC KPI Assurance Statement PDF 417.6KB
2018 Safety and environmental certifications:
•Bad Oldesloe - ISO 9001 and ISO 14001 PDF 412KB
•Dandenong - ISO 14001 PDF 508KB
•Dandenong - OHSAS 18001 PDF 510KB
•Notre Dame de Bondeville - ISO 14001 PDF 578KB
•Notre Dame de Bondeville - ISO 50001 PDF 532KB
•Notre Dame de Bondeville - OHSAS 18001 PDF 534KB
•OSS - ISO 14001 PDF 227KB
•OSS - OHSAS 18001 PDF 534KB
•South African Operations - ISO 14001 PDF 755KB
•South African Operations - OHSAS 18001 PDF 810KB
•Vallejo - OHSAS 18001 Certificate PDF 129KB
•Vitória - ISO 14001 PDF 1.5MB
•Vitória - OHSAS 18001 PDF 313KB
Intellectual
Capital
Manufactured
Capital
Human
Capital
Social & Relationship Capital
Natural
Capital
Financial
Capital
Intellectual Capital
Our intellectual capital supports our commitment to increasing the number of lives that benefit from our focused therapeutic basket of high quality, affordable medicines and products
Strategic objective
To enhance access to high quality, affordable medicines
Sustainability objectives
Sustaining life and health through high quality, affordable medicines
Material KPIs
- IMS Health (Pty) Limited value of total product pipeline for the next five years
- Number of product recalls
Assurance provider: Internal Audit
Manufactured Capital
The continued investment in our API facilities and FDF manufacturing capabilities aimed at delivering flexible and scalable manufacturing and enhanced operational synergies is a key enabler in supporting our mission to produce high quality, affordable medicines and products, enhancing access to healthcare in over 150 countries
Strategic objective
To achieve strategic advantage through our integrated supply chain
Sustainability objectives
Sustaining a cost-competitive manufacturing base
Material KPIs
- Return on total assets
- Normalised EBITDA margin
Assurance provider: PwC
Human Capital
Built on the foundation of our values and a commitment to the Group Code of Conduct, we strive to provide a safe, challenging and rewarding environment for each of our employees.
Strategic objective
To provide a safe, challenging and rewarding environment for our employees
Sustainability objectives
Creating an environment in which our employees can thrive
Providing a safe working environment
Material KPIs
- Average staff turnover
- Average training spend per employee
Assurance provider: Internal Audit
- Disabling incident frequency rate
- Lost work day frequency rate
Assurance provider: ERM
Social & relationship Capital
Responsible corporate citizenship is more than a compliance requirement, it is fundamental to our objectives and the way we do business. We recognise that there are inseparable linkages between our sustainable growth, our relationships with our stakeholders and its contribution to society in the broader context.
Strategic objective
To practise good corporate citizenship
Sustainability objectives
Promoting equality
Conducting our business in a responsible manner
Material KPIs
- BBBEE accreditation in South Africa*
- Percentage of female employees
- Percentage of females in top 100 positions in the Group
- Percentage of black employees in South Africa*
- Percentage of black employees in top 50 positions in South Africa
Assurance provider: Internal Audit
- BBBEE accreditation in South Africa
Assurance provider: Empowerdex
- Number of material incidents of legislative infringements
- FTSE/JSE Responsible Investment Index score
Natural Capital
As a manufacturer of quality medicines, APIs and nutritional products, we are reliant on the conversion and use of natural capital in creating value for our stakeholders. We recognise that our operations directly and indirectly impact the environment. Our Environmental Management Protocol affirms our commitment to reducing our impact on the environment through responsible environmental management, conservation and protection across all of our operations
Strategic objective
To practise good corporate citizenship
Sustainability objectives
Preserving the environment
Managing the efficient utilisation of scarce resources
Material KPIs
- Carbon emissions
- Waste recycled
- Water used
- Electricity used
Assurance provider: ERM
Financial Capital
We aim to create value for all of our stakeholders, by managing our financial capital in a commercially astute and diligent manner thereby harnessing opportunities for long-term sustainable economic growth.
Strategic objective
To create sustainable economic value for all of our stakeholders
Sustainability objectives
Adding economic value to stakeholders
Maintenance of financial health
Material KPIs
- Growth in revenue
- Growth in normalised headline earnings per share
- Growth in normalised EBITDA
- Return on ordinary shareholders’ equity
- Operating cash flow per share
- Leveraging ratio